Literature DB >> 26673908

Dialysis modality choice in elderly patients with end-stage renal disease: a narrative review of the available evidence.

Liviu Segall1, Ionut Nistor1,2, Wim Van Biesen2,3, Edwina A Brown4, James G Heaf5, Elizabeth Lindley6, Ken Farrington7,8, Adrian Covic1.   

Abstract

The number of elderly patients on maintenance dialysis has rapidly increased in the past few decades, particularly in developed countries, imposing a growing burden on dialysis centres. Hence, many nephrologists and healthcare authorities feel that greater emphasis should be placed on the promotion of home dialysis therapies such as peritoneal dialysis (PD) and home haemodialysis (HD). There is currently no general consensus as to the best dialysis modality for elderly patients with end-stage renal disease. In-centre HD is predominant in most countries, although it is widely recognized that PD has several advantages over HD, including the lack of need for vascular access, continuous slow ultrafiltration, less interference with patients' lifestyle and lower costs. Comparisons of outcomes between elderly patients on PD and HD rely on observational studies, as randomized controlled trials are lacking. The results of these studies are variable. However, most of them suggest that survival rates are largely similar between the two modalities, except for elderly patients with diabetes and/or beyond 1-3 years from dialysis initiation, in which cases HD appears to be superior. An equally important aspect to consider when choosing dialysis modality, particularly in this age group, is the quality of life, and in this regard most studies found no significant differences between PD and HD. In these circumstances, we believe that dialysis modality selection should be guided by patient's preference, based on comprehensive and unbiased information. A multidisciplinary team should review elderly patients starting on dialysis, aiming to identify possible barriers to PD and home HD, including physical, visual, cognitive, psychological and social problems, and to overcome such barriers by adequate care, education, psychological counselling and dialysis assistance.
© The Author 2015. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.

Entities:  

Keywords:  elderly; end-stage renal disease; haemodialysis; peritoneal dialysis; survival

Mesh:

Year:  2017        PMID: 26673908     DOI: 10.1093/ndt/gfv411

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  10 in total

1.  Assisted Peritoneal Dialysis as an Alternative to In-Center Hemodialysis.

Authors:  Edwina A Brown; Martin Wilkie
Journal:  Clin J Am Soc Nephrol       Date:  2016-07-27       Impact factor: 8.237

2.  Quality of life of elderly patients on peritoneal dialysis versus hemodialysis: a single-center study.

Authors:  Yosuke Saka; Tomohiko Naruse; Naoto Tawada; Mitsuhiro Tokomoto; Yuhei Noda; Yohei Taniguchi; Yasuko Nagahara; Ryoko Yamashita; Munetoshi Karasawa; Yuzo Watanabe; Yasuhiko Ito
Journal:  Clin Exp Nephrol       Date:  2016-12-20       Impact factor: 2.801

Review 3.  [Renal replacement therapy in the elderly].

Authors:  R Schindler
Journal:  Z Gerontol Geriatr       Date:  2016-07-21       Impact factor: 1.281

4.  Microbiology and Outcome of Peritoneal Dialysis-Related Peritonitis in Elderly Patients: A Retrospective Study in China.

Authors:  Panai Song; Dong Yang; Jine Li; Ning Zhuo; Xiao Fu; Lei Zhang; Hongqing Zhang; Hong Liu; Lin Sun; Yinghong Liu
Journal:  Front Med (Lausanne)       Date:  2022-04-14

5.  First-year mortality in incident dialysis patients: results of the Peridialysis study.

Authors:  James Heaf; Maija Heiro; Aivars Petersons; Baiba Vernere; Johan V Povlsen; Anette Bagger Sørensen; Naomi Clyne; Inga Bumblyte; Alanta Zilinskiene; Else Randers; Niels Løkkegaard; Mai Rosenberg; Stig Kjellevold; Jan Dominik Kampmann; Björn Rogland; Inger Lagreid; Olof Heimburger; Abdul Rashid Qureshi; Bengt Lindholm
Journal:  BMC Nephrol       Date:  2022-06-27       Impact factor: 2.585

6.  Factors Affecting Selection of a Dialysis Modality in Elderly Patients With Chronic Kidney Disease: A Prospective Cohort Study in Korea.

Authors:  Jang-Hee Cho; Jeong-Hoon Lim; Yeongwoo Park; Yena Jeon; Yon Su Kim; Shin-Wook Kang; Chul Woo Yang; Nam-Ho Kim; Hee-Yeon Jung; Ji-Young Choi; Sun-Hee Park; Chan-Duck Kim; Yong-Lim Kim
Journal:  Front Med (Lausanne)       Date:  2022-09-27

7.  Priority topics for European multidisciplinary guidelines on the management of chronic kidney disease in older adults.

Authors:  Sabine N van der Veer; Wim van Biesen; Pascale Bernaert; Davide Bolignano; Edwina A Brown; Adrian Covic; Ken Farrington; Kitty J Jager; Jeroen Kooman; Juan F Macías-Núñez; Andrew Mooney; Barbara C van Munster; Eva Topinkova; Nele J A Van Den Noortgate; Gerhard Wirnsberger; Jean-Pierre Michel; Ionut Nistor
Journal:  Int Urol Nephrol       Date:  2016-03-17       Impact factor: 2.370

8.  Trends in home dialysis use differ among age categories in past two decades: A Dutch registry study.

Authors:  Anna A Bonenkamp; Tiny Hoekstra; Marc H Hemmelder; Anita van Eck van der Sluijs; Alferso C Abrahams; Frans J van Ittersum; Brigit C van Jaarsveld
Journal:  Eur J Clin Invest       Date:  2021-08-02       Impact factor: 5.722

9.  Perceptions about the dialysis modality decision process among peritoneal dialysis and in-center hemodialysis patients.

Authors:  Jarcy Zee; Junhui Zhao; Lalita Subramanian; Erica Perry; Nicole Bryant; Margie McCall; Yanko Restovic; Delma Torres; Bruce M Robinson; Ronald L Pisoni; Francesca Tentori
Journal:  BMC Nephrol       Date:  2018-10-29       Impact factor: 2.388

10.  Interaction between central obesity and frailty on the clinical outcome of peritoneal dialysis patients.

Authors:  Gordon Chun-Kau Chan; Jack Kit-Chung N G; Kai-Ming Chow; Vickie Wai-Ki Kwong; Wing-Fai Pang; Phyllis Mei-Shan Cheng; Man-Ching Law; Chi-Bon Leung; Philip Kam-Tao L I; Cheuk Chun Szeto
Journal:  PLoS One       Date:  2020-10-26       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.